Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00683046What this trial is testingT-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesWho this might be right forAcute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more University of Chicago 204
Testing effectiveness (Phase 2)Study completedNCT00017342What this trial is testingBryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous LeukemiaWho this might be right forLeukemia Virginia Commonwealth University
Testing effectiveness (Phase 2)Ended earlyNCT03104270What this trial is testingCombination Study for High Risk Multiple Myeloma PatientsWho this might be right forMultiple Myeloma Oncotherapeutics 13
Testing effectiveness (Phase 2)Looking for participantsNCT05010122What this trial is testingASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more M.D. Anderson Cancer Center 42
Early research (Phase 1)Ended earlyNCT02848001What this trial is testingA Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic SyndromesWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Celgene 101
Early research (Phase 1)Looking for participantsNCT06994676What this trial is testingCBX-250 in Participants With Relapsed or Refractory Myeloid LeukemiasWho this might be right forHigh-risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)AML - Acute Myeloid Leukemia+1 more Crossbow Therapeutics, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00809276What this trial is testingAllo BMT Using Matched Related/Unrelated Donors With FluBu and HiCYWho this might be right forLymphomaMultiple MyelomaLeukemia+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Testing effectiveness (Phase 2)Ended earlyNCT06268574What this trial is testingSafety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AMLWho this might be right forAcute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome Ryvu Therapeutics SA 62
Large-scale testing (Phase 3)UnknownNCT00747877What this trial is testingHigh-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After ChemotherapyWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Leeds Cancer Centre at St. James's University Hospital 460
Testing effectiveness (Phase 2)UnknownNCT05809167What this trial is testingVenetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCTWho this might be right forAllogeneic Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 55
Large-scale testing (Phase 3)Study completedNCT00048230What this trial is testingPS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Millennium Pharmaceuticals, Inc. 620
Testing effectiveness (Phase 2)Ended earlyNCT00792506What this trial is testingPhase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Italfarmaco 1
Testing effectiveness (Phase 2)Study completedNCT00002833What this trial is testingPeripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes M.D. Anderson Cancer Center 53
Early research (Phase 1)Study completedNCT04901416What this trial is testingSafety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDSWho this might be right forAML, Adult RecurrentMDS Coeptis Therapeutics 8
Early research (Phase 1)Study completedNCT00401739What this trial is testingSafety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) CSL Limited 40
Early research (Phase 1)Looking for participantsNCT06146257What this trial is testingGLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic SyndromesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes GluBio Therapeutics Inc. 48
Early research (Phase 1)Looking for participantsNCT02508038What this trial is testingAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more University of Wisconsin, Madison 22
Testing effectiveness (Phase 2)UnknownNCT04749355What this trial is testingPhase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDSWho this might be right forAML, AdultMDSRelapse/Recurrence+1 more BioSight Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07591649What this trial is testingAdapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCTWho this might be right forRelapsed Adult AMLRefractory AMLAcute Myelogenous Leukemia Masonic Cancer Center, University of Minnesota 18